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Background: A high prevalence of chronic fatigue has previously been reported following giardiasis after a large
waterborne outbreak in Bergen, Norway in 2004. The aim of this study was to describe and evaluate differential
diagnoses and natural course of fatigue five years after giardiasis among patients who reported chronic fatigue
three years after the infection.
Methods: Patients who three years after Giardia infection met Chalder’s criteria for chronic fatigue (n=347) in a
questionnaire study among all patients who had laboratory confirmed giardiasis during the Bergen outbreak
(n=1252) were invited to participate in this study five years after the infection (n=253). Structured interviews and
clinical examination were performed by specialists in psychiatry, neurology and internal medicine/infectious
diseases. Fukuda et al’s 1994 criteria were used to diagnose chronic fatigue syndrome (CFS) and idiopathic chronic
fatigue (ICF). Self-reported fatigue recorded with Chalder Fatigue Questionnaire three and five years after infection
were compared.
Results: 53 patients were included. CFS was diagnosed in 41.5% (22/53) and ICF in 13.2% (7/53). Chronic fatigue
caused by other aetiology was diagnosed in 24.5% (13/53); five of these patients had sleep apnoea/hypopnoea
syndrome, six had depression and five anxiety disorder, and among these two had more than one diagnosis.
Fatigue had resolved in 20.8% (11/53). Self-reported fatigue score in the cohort was significantly reduced at five
years compared to three years (p<0.001).
Conclusion: The study shows that Giardia duodenalis may induce CFS persisting as long as five years after the
infection. Obstructive sleep apnoea/hypopnoea syndrome, depression and anxiety were important differential
diagnoses, or possibly comorbidities, to post-infectious fatigue in this study. Improvement of chronic fatigue in the
period from three to five years after giardiasis was found.
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Chronic fatigue syndrome (CFS) is a disease with un-
known pathogenesis that may be induced by infection,
trauma, cancer or undefined conditions, and is charac-
terized by abnormally long post-exertion rehabilitation,
incomplete/unsatisfactory relief by rest or sleep, sleep
disturbances, cognitive problems, tender lymph nodes,* Correspondence: kristine.morch@helse-bergen.no
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reproduction in any medium, provided the ormyalgia, headache, sore throat and other unspecific
symptoms [1-3].
CFS has been reported to affect 10% following Epstein
Barr virus (EBV) infection [4,5], and fatigue, depression
and hair loss is a common syndrome following Dengue
fever [6,7]. In controlled studies chronic fatigue has been
reported after Lyme borreliosis [8], Parvovirus B19 infec-
tion [9], Q fever [10] and Ross River virus infection [4].
Graded exercise and cognitive behaviour therapy have
been reported to be helpful treatment for some patients
[11-13].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Flow chart showing inclusion of patients among
laboratory confirmed cases of giardiasis during the outbreak in
Bergen in 2004.
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the diagnosis is based on the patient’s subjective report
of a combination of characteristic symptoms, lasting for
at least six months [1,3]. However, chronic fatigue severe
enough to affect normal life is a common symptom in a
range of chronic somatic and psychiatric disorders. Can-
cer; rheumatic, endocrine and neurologic disease; ob-
structive sleep apnoea/hypopnea syndrome (SAHS);
depression and anxiety; obesity, drug side effects and al-
cohol or drug abuse are among disorders that have to be
ruled out to establish the diagnosis CFS [1,3].
After a large outbreak of Giardia duodenalis in Bergen,
Norway in 2004 [14], all laboratory confirmed cases have
been followed up by repeated postal questionnaires
[15,16], and 46% reported chronic fatigue three years after
the Giardia infection [16].
In another cohort following the Giardia outbreak in
Bergen, Næss et al. [17] has recently reported CFS
among a selected group of patients referred to depart-
ment of neurology by their doctor due to fatigue com-
plaints one to three years after giardiasis; however, in
that study differential diagnoses were not reported and
clinical evaluation by internist and psychiatrist was not
performed.
Unspecific chronic fatigue has previously been
reported in 11% of the general Norwegian population
[18], underlining that chronic fatigue after an infectious
outbreak could possibly have many causes.
The main objective in the present study was to de-
scribe post-infectious fatigue, in the form of CFS and
idiopathic chronic fatigue (ICF) as defined by Fukuda
et al. [1], as well as differential diagnoses in the group of
patients who had self-reported chronic fatigue three
years after giardiasis. Secondary objectives were to de-
scribe the natural course of chronic fatigue based on
self-reported fatigue scores [19] three and five years after
the infection, and to identify factors associated with
chronic fatigue in this cohort.
Methods
Study population
Subjects were included among patients who fulfilled the
criteria for chronic fatigue in a postal questionnaire
study three years after giardiasis among all laboratory
confirmed Giardia cases in Bergen, Norway during an
outbreak in 2004 [16]. A flow chart describing inclusion
is shown in Figure 1. The questionnaire included
Chalder Fatigue Questionnaire [19] consisting of 11
validated questions recording physical and cognitive
manifestations of fatigue with four possible answers
(1=“less than usual”, 2= “not more than usual”,
3=“more than usual” and 4=“much more than usual”)
scored from 0 to 3, to give a possible total score be-
tween 0 and 33. Chronic fatigue is defined as at leastsix months duration of fatigue and a dichotomized
total score ≥ 4 (answers 0 and 1 dichotomized into 0,
and 2 and 3 into 1).
All patients who had chronic fatigue as well as a total
score 15–33 (n = 347/817), were eligible to participate in
the current study including clinical work-up and mag-
netic resonance imaging (MRI) of the brain. A cut-off of
15 was used in order to exclude those who had very mild
self-reported fatigue between 11 and 14. As an optional
part of the study, the patients were offered treatment
consisting of randomisation into two different treatment
programs performed by psychiatrists. Persons with age
above 70 or less than 18 years and those who had moved
away from the Bergen area were excluded for logistic
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cases were invited to participate. Patients were included
in the period of March 2009 to March 2010.
Data collection and diagnostic evaluation
All participants were interviewed and clinically exam-
ined by specialists in neurology, psychiatry and internal
medicine/infectious diseases. Structured interviews,
which included Fukuda et al’s 1994 diagnostic criteria
for CFS (CDC criteria) [1], as well as information
regarding demographic data and premorbid and inter-
current illness, were performed.
The Mini International Neuropsychiatric Interview-
MINI PLUS, a short standardized diagnostic interview
for DSM-IV and ICD-10 was used for evaluation of psy-
chiatric diagnoses [20], and Montgomery and Åsberg
depression rating scale (MADRS), which measure de-
pression severity on a 10-item scale, was used for rating
depressive symptoms [21].
A blood sample was taken from all patients, and
screened for a panel of biochemical, microbiological and
immunological parameters. Patients with positive Borre-
lia antibody test were asked to undergo a spinal tap with
analysis for intrathecal Borrelia antibody production.
Patients with elevated S-cortisol underwent a dexa-
methasone suppression test. Patients who reported snor-
ing and sleep apnoea were referred to an ENT specialist
for evaluation of SAHS. For other findings, patients were
referred to relevant specialists according to clinical prac-
tice. Stool microscopy and 18 S PCR were performed to
rule out chronic giardiasis.
Self - reported symptoms were recorded on Chalder
Fatigue Questionnaire [19] and on Rome II irritable
bowel syndrome (IBS) diagnostic questionnaires [22]
under the supervision of a study nurse.
The diagnoses CFS or idiopathic chronic fatigue (ICF)
were given according to the CDC criteria [1], where ICF
defined a condition similar to CFS not fulfilling all
criteria for a CFS case definition. Those who received
other diagnoses explaining fatigue were categorised as
“Chronic fatigue other aetiology”. When there was doubt
if a disease represented comorbidity or an exclusion cri-
terion for the diagnosis of CFS, it was categorised as
“Chronic fatigue other aetiology”. Those who had experi-
enced chronic fatigue following giardiasis earlier, but
who no longer had fatigue affecting normal life, were
categorised as “Recovered from fatigue”. CFS and ICF as
defined by Fukuda et al. [1] were grouped in the ana-
lyses, and categorised as “Giardia induced CFS/ICF”.
Diagnoses were evaluated based on all available data in-
cluding structured interviews and clinical examinations.
The psychiatric evaluation was performed by experi-
enced psychiatrists among the authors. A second psychi-
atric evaluation among patients taking part in thetreatment program was performed, with concordant
results.
Analyses
For each of the three response variables “Giardia
induced CFS/ICF”, “Chronic fatigue other aetiology” and
“Recovered from fatigue”, the possible risk factors were
analysed as explanatory variables using the Chi square
test for categorical variables and parametric and non-
parametric one way (Kruskal-Wallis) anova test for con-
tinuous variables. Total fatigue scores three and five
years after infection were compared using paired t-test,
and the change from three to five years compared be-
tween the groups using the one way anova. P-values ≤
0.05 were considered statistically significant. Statistical
analyses were performed using SPSS 18.0.
Ethics
The study was approved by the Regional Committee for
Medical and Health Research Ethics and by the Om-
budsman for Privacy in Research, Norwegian Social Sci-
ence Data Services. Written informed consent was
obtained from the participants.
Results
Among those invited, 20.9% (53/253) chose to partici-
pate in the study. Mean age was 43.5 (median 41.4,
range 20 – 69) years, and 77.4% (41/53) were women.
Giardia induced CFS/ICF was diagnosed in 54.7% (29/
53) (Table 1). Chronic fatigue caused by other disease
was diagnosed in 24.5% (13/53); five of these had SAHS,
six had depression and five had anxiety disorder, and
among these two had more than one diagnosis. Fatigue
had resolved in 20.8% (11/53).
Self-reported fatigue score in the whole cohort was
significantly reduced at five years compared to three
years (p < 0.001) (Figure 2). The score was reduced from
25 to 20 in the Giardia induced CFS/ICF category, from
21 to 19 among patients with other causes of chronic fa-
tigue and from 17 to 16 among those who had recov-
ered. However, these differences within the categories
were not statistically significant.
Demographic characteristics and comorbidity associated
with fatigue category is presented in Table 2. Age differed
between the categories (anova p-value = 0.029), however in
the pairwise comparison only the difference between those
who had recovered from fatigue, being younger, and those
who had chronic fatigue of other aetiology was significant
(p = 0.027 in Sidak multiple comparison).
Among patients with Giardia induced CFS/ICF, 51.7%
were on sick leave, 30.8% were on sick leave among
patients with chronic fatigue of other aetiology and none
of the patients who had recovered from fatigue were on
sick leave (p = 0.008).
Table 1 Distribution of diagnoses based on clinical evaluation five years after Giardia duodenalis infection in Bergen,
Norway in 2004 in 53 cases reporting chronic fatigue three years after giardiasis
Fatigue category Diagnosis
N (%) N (%)
Total 53 (100) 53 (100)
Giardia induced chronic fatigue 29 (54.7)
Chronic Fatigue Syndrome (CFS)1 22 (41.5)
Idiopathic Chronic Fatigue (ICF)1 7 (13.2)
Chronic fatigue other aetiology 13 (24.5)
Obstructive sleep apnoea/hypopnoea syndrome (SAHS) 4 (7.5)
Depression 4 (7.5)
Anxiety disorder 3 (5.7)
Depression, anxiety and SAHS 1 (1.9)
Depression and anxiety disorder 1 (1.9)
Recovered from fatigue 11 (20.8)
1Based on diagnostic criteria defined by Fukuda et al. (1994) [1].
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range 23.7 – 43.1) compared to a mean of 25.18 (SD
4.40, range 18.5 – 40.7) among patients without SAHS;
the difference was not statistically significant.
In the statistical analyses, no significant association was
found between gender, smoking habit, alcohol consumption
or comorbidity respectively and the fatigue categories.
Self-reported IBS according to Rome II criteria was
recorded in 59.6% (31/52).
Asthma was recorded in 20.8% (11/53), allergy in 58.5%
(31/53) and migraine in 22.6% (12/53). Asthma was signifi-
cantly associated with elevated IgE level (data not shown).
Comorbid agarophobia or dysthymia not severe enough to
exclude the diagnosis of CFS were found in four patients.
Results from biochemical and microbiological blood
tests were not significantly different in the three categor-
ies (data not shown). S-cortisol was elevated in five
patients; none had findings suggesting Cushing’s disease,0
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Figure 2 Self reported Fatigue scores (mean) 3 and 5 years after giar
reduction in fatigue score (p<0.001). The scores at 3 and 5 years were cfour had negative dexamethasone test and one positive
dexamethasone test was explained by use of oral contra-
ceptives. Borrelia IgG antibody was elevated in three
patients without previous diagnosis of borreliosis, one
had negative spinal fluid examination for intrathecal
antibody production, two did not undergo spinal tap but
had no findings suggesting neuroborreliosis on examin-
ation. Enterovirus antibody titers were elevated in 12
patients (range 16 – 64), and IgE was elevated in 11
patients. D-vitamin below normal range was found in 16
patients (range 17 – 48 nmol/L).
Previous morbidity before present investigation asso-
ciated with fatigue categories is presented in Table 3.
Four patients reported a self-limiting period of chronic
fatigue prior to giardiasis, three of these following
Chlamydia psittachi, Yersinia enterocolitica infection
and mononucleosis respectively. Ten patients had previ-
ously had infections that are reported to have thecovered
m fatigue 
Fatigue score 3 years
after giardiasis
Fatigue score 5 years
after giardiasis
diasis grouped by fatigue category, showing a significant
ompared using paired t-test.
Table 2 Demographic characteristics and comorbidity among patients reporting chronic fatigue following giardiasis,
associated with fatigue category five years after the infection
Characteristics All cases Giardia induced CFS/ICF Chronic fatigue other aetiology Recovered from fatigue
N = 53 N = 29 N = 13 N = 11
Age, mean (SD) 43.5 (11.29) 44.4 (9.04) 47.9 (14.97) 35.9 (8.68)
Gender
Female 41 23 12 6
Male 12 6 1 5
On sick leave1
Yes 19 15 4 -
No 34 14 9 -
Daily smoker
Yes 11 8 2 1
No 42 21 11 10
BMI2, mean (SD) 25.6 (4.95) 24.5 (3.06) 28.34 (8.29) 25.5 (3.43)
Alcohol consumption3(u/m)
mean (SD) 10.5 (10.18) 10.9 (11.04) 9.46 (9.40) 10.7 (9.68)
Somatic comorbidity
Abdominal problems 45 23 13 9
IBS Rome II 31 17 7 6
Pregnancy 1 1 - -
Asthma 11 4 5 2
Allergy 31 14 11 6
Diabetes type 2 2 - 2 -
Hypothyreosis 2 1 1 -
Myasthenia gravis 1 - 1 -
Epilepsy 1 1 - -
Migraine 12 9 3 -
Psoriasis 3 1 2 -
Hypertension 3 1 2 -
Hypercholesterolemia 2 - 2 -
IgA nephritis 1 1 - -
Psychiatric comorbidity
Agarophobia 1 1 - -
Dysthymia 3 2 1 -
Data are presented as number of cases (n), if not other stated. Each patient may have more than one diagnosis.
Abbreviations: CFS, Chronic Fatigue Syndrom; SD, standard deviation; BMI, body mass index; IgA, immunoglobuline A.
1Sick leave range; 20, 50, 60, 70 and 100%, grouped together.
2Missing values (excluded), 5.
3Missing values (excluded), 2.
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liosis, mononucleosis or Dengue fever, without fatigue
following these infections.
Fatigue score at three years differed between the
categories (anova p-value <0.001), however in pairwise
comparisons only the difference between Giardia
induced CFS/ICF, having a higher score, and those who
had recovered was significant (p<0.001 in Sidak
multiple comparison).A previous severe abdominal condition was signifi-
cantly associated (p=0.031) with having chronic fatigue
with other aetiology. In the statistical analyses, no
other significant association was found between fatigue
category and previous morbidity. Among all patients,
19 (35.8%) had previous depression and six (11.3%)
had experienced whip lash trauma. Seven (13.2%)
had a previous musculoskeletal disorder diagnosis
(Table 3).
Table 3 Previous medical history among patients who reported chronic fatigue 3 years after giardiasis, associated with
fatigue categories 5 years after the infection
Previous history All cases Gxiardia induced CFS/ICF Chronic fatigue other aetiology Recovered from fatigue
N = 53 N = 29 N = 13 N = 11
Fatigue score at 3 years mean,
range (SD)
23, 15–33 (5.80) 25, 15–33 (5.20) 21, 15–32 (6.02) 18, 15–22 (1.86)
Fatigue before giardiasis, induced by
Mononucleosis 1 1 - -
Chlamydia psittachi1 2 - 1 1
Yersinia enterocolitica1 1 - 1 -
Undefined 1 1 - -
Infections with reported potential
to induce fatigue
Borreliosis 2 0 2 -
Mononucleosis 7 3 3 1
Dengue infection 1 1 - -
Previous diagnoses
Sleep apnoea2 1 1 - -
Whip lash trauma 6 3 - 3
Musculoskeletal3 7 3 4 -
Thyreoiditis 1 1 - -
Silicon breast implant 1 1 - -
Meningitis 1 1 - -
Pneumonia4 3 1 1 1
Pyelonephritis 1 1 - -
Tonsillectomy 1 - - 1
Cervical dysplasia 3 3 - -
Syncope 2 1 1 -
Adipositas surgery 2 1 1 -
Severe abdominal diagn5 11 3 6 2
Infectious gastroenteritis 7 2 3 2
Irritable bowel syndrome 3 2 - 1
Cancer6 2 - 2 -
Depression 19 11 6 2
Anxiety disorder 2 - 1 1
Alcohol overuse 1 - 1 -
Data are presented as number of cases (n) if not other stated. Each patient may have more than one diagnosis.
1One patient had had fatigue after both Yersinia and Chlamydia infection.
2Recovered after adipositas surgery.
3Including the following diagnoses: Polyarthrosis, chronic single or multiple joint pain, fibromyalgia, cervical prolaps.
4Two patients had pneumonia due to Chlamydia psittachi.
5Including the following: Acute abdomen leading to hospitalisation; ulcus ventriculi or duodeni; inflammatory bowel disease; cholecysteoctomised; cholecystitis;
cholecystolithiasis; appendicitis; faecal incontinence following haemorrhoid operation.
6Cancer ovarii; cancer mamma.
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In this study, CFS/ICF was diagnosed in 54.7% among 53
patients investigated five years after Giardia duodenalis
infection, who had reported chronic fatigue three years
after the infection. As much as 25% of the patients in this
cohort had other diagnoses possibly explaining chronicfatigue underlining the importance of evaluating differen-
tial diagnoses.
A significant reduction in self-reported fatigue at five
years compared to three years after giardiasis was found,
suggesting that chronic fatigue following giardiasis has a
protracted but self-limiting course, also supported by the
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Giardia chronic fatigue earlier had recovered at five years.
All chronic fatigue patients not diagnosed as Giardia
induced CFS/ICF had SAHS, depression or anxiety.
According to Fukuda et al. (CDC criteria), sleep apnoea
is an exclusion criteria for the diagnosis of CFS [1]. In a
report from patients evaluated in a CFS referral clinic in
UK, sleep apnoea was the most common somatic cause
of fatigue wrongly diagnosed as CFS by general practi-
tioners [23]. However, other researchers argue that
SAHS is a common comorbidity rather than exclusion
criterion in CFS. Polysomnographic evaluation revealed
SAHS in 60% among patients with CFS in one report
from Canada [24]. Further studies by their research
group reported that treatment of SAHS with continuous
positive airway pressure (CPAP) did not improve fatigue
in patients with CFS and SAHS, supporting that SAHS
was a comorbid disease and not an exclusion criterion
to the CFS diagnosis [25]. Furthermore, both patients
with CFS, and patients with SAHS without CFS, experi-
enced worse sleep quality, fatigue and psychological
functioning compared to a healthy control group [25],
supporting our finding that SAHS is an important differ-
ential diagnosis to CFS but also may be a possible
comorbidity.
Psychiatric illness in chronic fatigue may be a comor-
bid condition or a consequence due to reduced quality
of life, rejection and stigmatization often experienced by
these patients. Severe psychiatric illness is defined as an
important exclusion criterion to the diagnosis of CFS
[1], as such disorders will often have chronic fatigue as
implicit symptom of the illness. However, depression
and anxiety are commonly misdiagnosed as CFS [23,26]
with potentially severe consequences due to lack of ad-
equate diagnosis and treatment. It may be difficult to
differentiate psychiatric illness from secondary psycho-
logical symptoms found in CFS [25], and evaluation by a
psychiatrist may be needed in order to establish the cor-
rect diagnosis and treatment.
In our study, CFS was excluded when SAHS, depres-
sion and anxiety were diagnosed, although it should be
taken into account that giardiasis may have contributed
to or triggered chronic fatigue also among these
patients.
A high prevalence of IBS [16,27] and a highly signifi-
cant association between chronic fatigue and IBS has
previously been reported among patients who had la-
boratory confirmed giardiasis during the Bergen out-
break [16]. A high level of IBS comorbidity was
confirmed in the present study (Table 2). Interestingly, a
high prevalence of comorbid allergy (58.5%) and asthma
(20.3%) was recorded in the present study, supporting
the possible association between chronic fatigue and
atopic disease reported and discussed previously [28].Those who had recovered from chronic fatigue were
significantly younger than those who had chronic fatigue
with other aetiology, supporting that higher age could be
a risk factor for chronic fatigue as previously reported
after the Giardia outbreak [15]. No potential risk factors
were found to be significantly associated with CFS/ICF
compared to the other categories. However, the limited
number of patients should be taken into account when
interpreting the analyses of factors potentially associated
with CFS/ICF in this study.
The participation rate was relatively low (21%), pos-
sibly influenced by factors such as lack of energy to par-
ticipate in the extensive work up, interpretation of
invitation to psychiatric treatment as an unwanted in-
sinuation of chronic fatigue having psychiatric aetiology,
recovery from chronic fatigue or severe fatigue hamper-
ing the patient’s ability to participate. However, the lack
of representativeness among all Giardia positive indivi-
duals during the Bergen outbreak does not have import-
ant implications for the interpretation of the results in
this clinical study, since it describes CFS and differential
diagnoses in a cohort of self-reported fatigue following
giardiasis, and does not aim at identifying the prevalence
of post-Giardia CFS in the general population.
A strength in this study is the thorough clinical evalu-
ation as basis for the CFS/ICF diagnosis. In a study by
Næss et al. [17] reporting CFS in 60% one to three years
after giardiasis during the Bergen outbreak, patients
were selected among those referred to department of
neurology and not by invitation among all laboratory
confirmed cases reporting chronic fatigue as in the
present study and results are therefore not comparable.
Næss et al. report a high level of depression and anxiety
among their patients, however, evaluation by psychiatrist
was not performed to evaluate these conditions as differ-
ential diagnoses to CFS.
The pathophysiology in post-infectious chronic fatigue
is not well described, and in Giardia induced chronic fa-
tigue even less, but symptom pattern as well as infec-
tious aetiology would support the hypothesis that
immunological dysfunction could play a role. In a recent
report from the present cohort investigating previously
reported markers of immune dysfunction in CFS, a
decreased level of natural killer cells was found among
CFS patients, suggesting a possible immunological ab-
normality that should be investigated further [29].
Conclusions
This study confirms that Giardia duodenalis, a parasite
previously regarded to be responsible for mainly uncom-
plicated infections, is capable of inducing chronic fatigue
syndrome that may persist as long as five years after the
infection. Improvement of fatigue symptoms at five years
compared to three years after giardiasis was found.
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sion and anxiety disorders were important differential
diagnoses, or possible comorbidities, to post-giardiasis
CFS/ICF in this cohort.
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